Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study

BJU International

Volumn 100, Issue 5, 2007, Pages 1091-1096

  Tang, Jie ^a   Yang, Jing Chun ^a   Zhang, Yan ^a   Liu, Xin ^a   Zhang, Lihai ^a   Wang, Zhili ^a   Li, Junlai ^a   Luo, Yukun ^a   Xu, Jianhong ^a   Shi, Huaiyin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Benign prostatic hyperplasia; Hypoechoic nodule; Peripheral zone; Transrectal ultrasonography

Indexed keywords

ANDROGEN RECEPTOR; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANALYTIC METHOD; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NICK END LABELING; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; AGED, 80 AND OVER; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ANDROGEN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 35148897352     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07081.x     Document Type: Article

References (29)

1. Foster CS. Pathology of benign prostatic hyperplasia. Prostate 2000 9 (Suppl. 4
2. Ramsey EW. Benign prostatic hyperplasia: a review. Can J Urol 2000 7 : 1135
3. McNeal JE. Development and comparative anatomy of the prostate. In Grayhack JT, Wilson JD, Scherbenske MJ, Benign Prostate Hyperplasia. DHEW Publication (NIH) 76-1113, 1975 : 1
4. Robert L. The prostate. In Carol MR, Stephanie RW, Williams J Diagnostic Ultrasound. DNLM Publication (WN) 208 D5357, 1997 : 400
5. Lee F, Gray JM, McLeary RD et al. Prostatic evaluation by transrectal sonography: criteria for diagnosis of early carcinoma. Radiology 1986 158 : 91 5
6. Oyen RH, Van de Voorde WM, Van Poppel HP et al. Benign hyperplastic nodules that originate in the peripheral zone of the prostate gland. Radiology 1993 189 : 707 11
7. Egawa S, Ohori M, Uchida T et al. Nodular hyperplasia in the peripheral zone of the prostate gland. Br J Urol 1994 74 : 520 1
8. Van de Voorde WM, Oyen RH, Van Poppel HP et al. peripherally localized benign hyperplastic nodules of the prostate. Mod Pathol 1995 8 : 46 50
9. Patel U, Rickards D. The diagnostic value of color Doppler flow in the peripheral zone of the prostate, with histological correlation. Br J Urol 1994 74 : 590 5
10. Tang J, Li X, Wang N et al. Correlation between hypoechoic nodules on ultrasonography and benign hyperplasia in the prostatic outer gland. J Ultrasound Med 2005 24 : 483 8
11. Lee C, Sensibar JA, Dudek SM et al. Prostatic ductal system in rats. Regional variation in morphological and functional activities. Biol Reprod 1990 43 : 1079 82
12. Maygarden SJ, Strom S, Ware JL. Localization of EGF receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Path Laboratory Med 1992 116 : 269
13. Ware JL. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev 1993 12 : 287
14. Moses HL, Yang EY, Pietenpol JA. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990 63 : 245 7
15. Buttyan R, Shabsigh A, Perlman H et al. Regulation of apoptosis in the prostate gland by androgenic steroids. Trends Endocrinol Metab 1999 10 : 47 54
16. Chang C, Saltzman A, Yeh S et al. Androgen receptor: an overview. Crit Rev Eukaryot Gene Exp 1995 5 : 97 125
17. Klocker H, Culig Z, Eder IE et al. Mechanism of androgen receptor activation and possible implications for chemoprevention trials. Eur Urol 1999 35 : 413 9
18. Zeng L, Rowland RG, Lele SM et al. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, 27Kip1, and Smad4 in benign, premalignant, and malignant human prostate. Hum Pathol 2004 35 : 290 7
19. Haussler O, Epstein JI, Amin MB et al. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer. Hum Pathol 1999 30 : 1077 86
20. Shapiro E, Becich MJ, Hartanto V et al. the relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. J Urol 1992 147 : 1293
21. Cunha GR, Ricke W, Thomson A et al. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol 2004 92 : 221 36
22. Lee F, Torp-Pedersen ST, Siders DB et al. Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology 1989 170 : 609 15
23. Xia SJ, Xu CX, Du DL et al. Apoptosis and hormonal milieu in ductal system of normal prostate and benign prostatic hyperplasia. Asia J Androl 2001 3 : 131 4
24. Hockenbery DM, Nunez G, Milliam C et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1999 348 : 334 6
25. Huang X, Lee C. Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta. Front Biosci 2003 8 : 740 9
26. Ma QJ, Gu XQ, Cao X et al. Effect of beta radiation on TGF-beta1 and bFGF expression in hyperplastic prostatic tissues. Asian J Androl 2005 7 : 49 54
27. Sun HB, Xia SJ, Tang XD. Expression of different genes in transitional zone and peripheral zone of human normal prostate. Natl Med J China 2005 85 : 610 3
28. Sciarra F, Monti S, Adamo MV. Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue. Urol Res 1995 23 : 387 90
29. Zlota A, Sattar AA, Wespes E et al. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study. Urology 1996 47 : 329 34